Sumitomo Mitsui DS Asset Management Company Ltd Grows Position in The Clorox Company $CLX

Sumitomo Mitsui DS Asset Management Company Ltd raised its stake in shares of The Clorox Company (NYSE:CLX) by 81.5% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 24,779 shares of the company’s stock after purchasing an additional 11,124 shares during the quarter. Sumitomo Mitsui DS Asset Management Company Ltd’s holdings in Clorox were worth $3,055,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in CLX. Invesco Ltd. raised its stake in Clorox by 138.3% in the 2nd quarter. Invesco Ltd. now owns 3,245,175 shares of the company’s stock worth $389,648,000 after acquiring an additional 1,883,465 shares during the last quarter. Norges Bank acquired a new position in shares of Clorox in the second quarter valued at about $190,429,000. Arrowstreet Capital Limited Partnership increased its holdings in shares of Clorox by 218.4% in the second quarter. Arrowstreet Capital Limited Partnership now owns 1,249,127 shares of the company’s stock valued at $149,983,000 after purchasing an additional 856,873 shares during the period. Worldquant Millennium Advisors LLC purchased a new position in shares of Clorox in the second quarter worth about $71,856,000. Finally, Nuance Investments LLC lifted its holdings in shares of Clorox by 182.5% during the second quarter. Nuance Investments LLC now owns 848,106 shares of the company’s stock worth $101,832,000 after purchasing an additional 547,839 shares during the period. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Clorox Trading Up 0.8%

CLX stock opened at $107.00 on Tuesday. The Clorox Company has a 52-week low of $96.66 and a 52-week high of $164.22. The company has a quick ratio of 0.50, a current ratio of 0.76 and a debt-to-equity ratio of 18.01. The firm has a market cap of $13.05 billion, a P/E ratio of 16.80, a PEG ratio of 0.53 and a beta of 0.58. The company’s 50-day simple moving average is $102.96 and its 200-day simple moving average is $115.52.

Clorox (NYSE:CLX) last announced its quarterly earnings results on Monday, November 3rd. The company reported $0.85 earnings per share for the quarter, beating the consensus estimate of $0.78 by $0.07. The firm had revenue of $1.43 billion during the quarter, compared to analyst estimates of $1.41 billion. Clorox had a return on equity of 358.39% and a net margin of 11.68%.Clorox’s revenue for the quarter was down 18.9% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.86 EPS. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. As a group, equities analysts forecast that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Stockholders of record on Wednesday, January 28th will be given a dividend of $1.24 per share. The ex-dividend date is Wednesday, January 28th. This represents a $4.96 dividend on an annualized basis and a dividend yield of 4.6%. Clorox’s dividend payout ratio (DPR) is 77.86%.

Analysts Set New Price Targets

A number of equities analysts have issued reports on CLX shares. TD Cowen reduced their price target on shares of Clorox from $117.00 to $108.00 and set a “hold” rating for the company in a research report on Thursday, January 8th. Rothschild & Co Redburn reduced their target price on shares of Clorox from $120.00 to $115.00 and set a “neutral” rating for the company in a report on Wednesday, November 5th. Jefferies Financial Group restated a “buy” rating and set a $152.00 target price on shares of Clorox in a research report on Tuesday, November 4th. Morgan Stanley lowered their price target on shares of Clorox from $137.00 to $125.00 and set an “equal weight” rating on the stock in a report on Tuesday, November 4th. Finally, JPMorgan Chase & Co. reduced their price objective on Clorox from $127.00 to $120.00 and set a “neutral” rating for the company in a research note on Tuesday, November 4th. One equities research analyst has rated the stock with a Buy rating, fourteen have given a Hold rating and four have issued a Sell rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Reduce” and a consensus target price of $122.88.

Insider Activity

In related news, Director Pierre R. Breber purchased 4,000 shares of the company’s stock in a transaction that occurred on Friday, November 21st. The shares were purchased at an average price of $104.13 per share, with a total value of $416,520.00. Following the purchase, the director owned 13,000 shares of the company’s stock, valued at $1,353,690. The trade was a 44.44% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.63% of the stock is owned by company insiders.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.